Cellular compatibility of bone-like apatite containing silicon species

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 1, 2008, Pages 140-144

  Obata, Akiko ^a   Kasuga, Toshihiro ^a  

^a NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Bone like hydroxyapatite; Cellular compatibility; Poly(lactic acid); Siloxane; Vaterite

Indexed keywords

APATITE; HYDROXYAPATITE; LACTIC ACID; OSTEOBLASTS; TISSUE ENGINEERING;

BONE-LIKE HYDROXYAPATITE; CELLULAR COMPATIBILITY; POLY(LACTIC ACID); SILOXANE;

BONE;

APATITE; BIOMATERIAL; CALCIUM CARBONATE; HYDROXYAPATITE; SILICONE; SILOXANE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL PROLIFERATION; COMPOSITE GRAFT; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; NONHUMAN; OSSIFICATION; TISSUE DIFFERENTIATION; TISSUE ENGINEERING;

3T3 CELLS; ANIMALS; BONE AND BONES; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELL LINE; DURAPATITE; HUMANS; MICE; OSTEOBLASTS; SILICON;

EID: 40449104804     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31509     Document Type: Article

References (18)

1. Xue JM, Shi M. PLGA/mesoporous silica hybrid structure for controlled drug release. J Controlled Release 2004;98:209-217.
2. Kim S-S, Park MS, Jeon O, Choi CY, Kim B-S. Poly(lactide- co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 2006;27:1399-1409.
3. Zhang K, Wang Y, Hillmyer MA, Francis LF. Processing and properties of porous poly(L-lactide)/bioactive glass composites. Biomaterials 2004;25:2489-2500.
4. Kasuga T, Maeda H, Kato K, Nogami M, Hata K, Ueda M. Preparation of poly(lactic acid) composites containing calcium carbonate (vaterite). Biomaterials 2003;24:3247-3253.
5. Kasuga T, Maeda H, Jell G, Notingher I, Hench LL. Preparation of vaterite/poly(lactic acid) composites with excellent apatite-forming ability. Key Eng Mater 2005;284-286:449-457.
6. Maeda H, Kasuga T, Nogami M. Vaterite/poly(lactic acid) composite biomaterials. Arch Bioceram Res 2003;3:110-113.
7. Maeda H, Kasuga T, Nogami M, Ota Y. Preparation of calcium carbonate composites and their apatite-forming ability in simulated body fluid. J Ceram Soc Japan 2004;112:S804-S808.
8. Chou Y-F, Huang W, Dunn JCY, Miller TA, Wu BM. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials 2005;26:285-295.
9. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-734.
10. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-465.
11. Patel N, Best SM, Bonfield W, Gibson IR, Hing KA, Damien E, Revell PA. A comparative study on the invivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Mater Sci Mater Med 2002;13:1199-1206.
12. Maeda H, Kasuga T, Hench LL. Preparation of poly(L-lactic acid)-polysiloxane-calcium carbonate hybrid membranes for guided bone regeneration. Biomaterials 2006;27:1216-1222.
13. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Effect of sintered silicate-substituted hydroxyapatite on remodelling processes at the bone-implant interface. Biomater 2004;25:3303-3314.
14. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials 2003;24:4609-4620.
15. Maeda H, Ishida EH, Kasuga T. Preparation of poly(L-lactic acid) hybrid membrane with silicon-ion-releasing ability. Key Eng Mater 2007;330-332:1305-1308.
16. Gibson IR, Huang J, Best SM, Bonfield W, Enhanced in vitro cell activity and surface apatite layer formation on novel silicon-substituted hydroxyapatites. Bioceramics 1999;12:191-194.
17. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J Biomed Mater Res 2001;55:151-157.
18. Gough JE, Jones JR, Hench LL. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004;25:2039-2046.